Typhoid vaccine: a case for inclusion in national program.

Authors:
Address: Department of Community Medicine, Maulana Azad Medical College, New Delhi, India. drpragya@gmail.com
Journal:

Publication:

abstract

Typhoid has been reported to be a common and significant cause of morbidity in pre-school and school-age children in the endemic countries like India. The incidence of typhoid has been reported to be as high as 27.3 per 1000 person-years in children less than 5 years of age. Serious complications occur in about 10% of cases requiring hospitalization. The mean cost of treatment per episode of blood culture-confirmed typhoid fever has been calculated as INR 3,597 (1996 prices) in an outdoor setting, whereas in case of hospitalization, the cost of illness increases by several folds (INR 18,131). Vi polysaccharide vaccine is safe, efficacious and affordable for use as a cost-effective public health tool to protect children from typhoid and related complications, when given at 2 and 5 years of age as a part of national Immunization Schedule.

Related Articles
Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
J Health Popul Nutr. 2004
Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
Bahl R, Sinha A, Poulos C, Whittington D, Sazawal S, Kumar R, Mahalanabis D, Acosta CJ, Clemens JD, Bhan MK. J Health Popul Nutr. 2004 Sep; 22(3):304-10.
The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Vaccine. 2008
The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D, Anh DD, Agtini M, Bhutta Z, DOMI Typhoid Economics Study Group. Vaccine. 2008 Nov 25; 26(50):6305-16. Epub 2008 Oct 7.
Typhoid fever in children aged less than 5 years.
Lancet. 1999
Typhoid fever in children aged less than 5 years.
Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, Rao M, Naficy A, Clemens JD, Bhan MK. Lancet. 1999 Aug 28; 354(9180):734-7.
Review New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
Postgrad Med. 1996
Review New and improved vaccines. Promising weapons against varicella, hepatitis A, and typhoid fever.
Conrad DA, Jenson HB. Postgrad Med. 1996 Oct; 100(4):113-8, 121-5, 127.
Review Typhoid vaccination: the Asian experience.
Expert Rev Vaccines. 2008
Review Typhoid vaccination: the Asian experience.
DeRoeck D, Ochiai RL, Yang J, Anh DD, Alag V, Clemens JD. Expert Rev Vaccines. 2008 Jul; 7(5):547-60.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.